Trilogy Writing & Consulting

Trilogy Writing & Consulting

Freiburg, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Trilogy Writing & Consulting is a long-established, privately-held service provider in the biopharmaceutical regulatory affairs ecosystem. It specializes exclusively in high-quality medical writing for clinical and regulatory documentation, serving as an extension of its clients' teams. With over 20 years of experience, the company focuses on streamlining documentation processes to improve efficiency, reduce time-to-review, and support successful drug development and approval. Its value proposition is built on deep scientific expertise, proactive project management, and a commitment to clarity and regulatory compliance.

Regulatory Writing

Technology Platform

Proprietary methodology and quality-controlled processes for regulatory document creation, leveraging deep scientific expertise, industry best practices, and PIF Tick-accredited plain language writing.

Opportunities

Growing biopharma R&D spend and increasing regulatory complexity drive sustained demand for outsourced medical writing.
The mandate for plain-language trial summaries (e.g., EU Lay Summaries) creates a new, specialized service line where Trilogy's PIF Tick accreditation provides a competitive edge.

Risk Factors

Business is cyclical and tied to pharmaceutical R&D budgets.
High dependence on key personnel and scientific experts.
Intense competition from other writing firms, CROs, and in-house teams at large sponsors.

Competitive Landscape

Competes with other specialized medical writing consultancies, full-service CROs that offer writing services, and the internal medical writing departments of large pharmaceutical companies. Differentiation is based on deep expertise, quality, client partnership approach, and niche capabilities like plain-language writing.